Tuesday, April 24, 2018
 
 
Company News: Page (1) of 1 - 12/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

By Globenewswire

BURLINGTON, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President, Commercial Operations, will participate in a fireside chat at the BMO Capital Markets Prescriptions for Success Healthcare Conference in New York City on Thursday, December 14, 2017 at 8:30 am ET. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com/.

About Flexion Therapeutics

Flexion Therapeutics (Nasdaq:FLXN) is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of the Boston Business Journal's 2017 Best Places to Work and one of the Top Places to Work in Massachusetts by The Boston Globe.

Corporate Contact:

Scott YoungSr. Director, Corporate Communications & Investor Relations


Flexion Therapeutics, Inc.
T: 781-305-7194
[email protected]


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines